Nicox: Participation in Major Congresses in 2025

Ophthalmology company Nicox announced its presence at the American Glaucoma Society (AGS) 2025 Annual Meeting and other major industry events, February 26-March 2 in Washington, D.C., highlighting a comparative analysis of intraocular pressure with NCX 470 in the Phase 3 Mont Blanc study.

In terms of participation, Nicox plans to speak at key forums such as the Allinvest Securities Biomed Forum in Paris on February 4, and Investor Access from April 1-2. Other events include ARVO 2025 in Salt Lake City, as well as the BIO International Convention in Boston.